miRecule and Rio Biofarma Brasil Partner to Advance Next-Generation RNA Delivery Technologies miRecule, Inc., a biotechnology company focused on developing next-generation RNA therapeutics for rare genetic diseases, has entered into…
Cofactor Genomics Appoints Renowned Oncologist Dr. Howard H. Bailey as Chief Medical Officer to Advance Precision Immunotherapy Diagnostics Cofactor Genomics, a commercial-stage diagnostics company focused on advancing precision oncology through…
Johnson & Johnson Partners with Sail Biomedicines to Advance In Vivo CAR-T Therapies for Immune-Mediated Diseases Johnson & Johnson has announced a broad strategic collaboration with Sail Biomedicines, a biotechnology…
Latigo Biotherapeutics Publishes Positive Phase 2 LTG-001 Acute Pain Trial Results in The New England Journal of Medicine Latigo Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing innovative non-opioid…
Pfizer and BioNTech Receive European Commission Approval for 2026–2027 XFG-Adapted COVID-19 Vaccine Across Europe Pfizer Inc. and BioNTech SE have announced that the European Commission (EC) has granted marketing authorization…
Teleflex Receives Historic FDA Approval for EZPLAZ™ Freeze Dried Plasma, Expanding Emergency Blood Transfusion Options Teleflex Incorporated, a global leader in medical technology and innovative healthcare solutions, has announced a…
VDyne Launches Pivotal TRIVITA Study, Treats First Patient with TriNova™ Transcatheter Tricuspid Valve Replacement System VDyne Inc., a privately held medical device company focused on advancing structural heart therapies, has…
PK MED Strengthens Leadership and Scientific Governance to Advance ARTHRELIS and ENGRAFTIS Development Programs PK MED, a French biotechnology company established by healthcare investment firm Truffle Capital, has announced a…
Virta Health Study Suggests Nutrition-Based Metabolic Care May Significantly Reduce Risk of Chronic Kidney Disease Virta Health, a leader in reversing metabolic disease through individualized nutrition-based care, has announced the…
Aqtual Strengthens Executive Leadership with Appointment of Daniil Kalyuzhny as Chief Financial Officer to Support Next Phase of Growth Aqtual, Inc., a precision medicine company pioneering active chromatin cell-free DNA…
Niagen Bioscience Publishes New Research Linking Niagen® Supplementation to Reduced Biological Aging in Skeletal Muscle Niagen Bioscience, Inc., a global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy aging…
Vergent Bioscience Reports Promising Phase 2B Results for Abenacianine, Advancing Real-Time Tumor Imaging During Lung Cancer Surgery Vergent Bioscience, a clinical-stage biotechnology company focused on developing innovative tumor-targeted imaging technologies,…